Projects / Programmes
Role of lysosomes and lysosomal proteases in cellular signaling
Code |
Science |
Field |
Subfield |
1.05.00 |
Natural sciences and mathematics |
Biochemistry and molecular biology |
|
Code |
Science |
Field |
B000 |
Biomedical sciences |
|
Code |
Science |
Field |
1.07 |
Natural Sciences |
Other natural sciences |
Lysosomes, cathepsins, apoptosis, autophagy, cancer, therapy
Researchers (14)
no. |
Code |
Name and surname |
Research area |
Role |
Period |
No. of publicationsNo. of publications |
1. |
23573 |
PhD Dejan Caglič |
Biochemistry and molecular biology |
Researcher |
2010 |
53 |
2. |
00449 |
PhD Iztok Dolenc |
Biochemistry and molecular biology |
Researcher |
2012 - 2013 |
110 |
3. |
34090 |
PhD Gabriele Droga Mazovec |
Biochemistry and molecular biology |
Researcher |
2012 - 2013 |
38 |
4. |
18801 |
PhD Marko Fonović |
Biochemistry and molecular biology |
Researcher |
2010 - 2013 |
187 |
5. |
29470 |
PhD Katarina Pegan |
Biochemistry and molecular biology |
Researcher |
2011 - 2013 |
44 |
6. |
24764 |
PhD Ana Petelin |
Cardiovascular system |
Researcher |
2010 - 2011 |
231 |
7. |
25642 |
PhD Urška Požgan |
Pharmacy |
Researcher |
2010 |
24 |
8. |
21560 |
PhD Urška Repnik |
Microbiology and immunology |
Researcher |
2010 - 2011 |
149 |
9. |
28485 |
PhD Aleš Špes |
Biochemistry and molecular biology |
Junior researcher |
2010 - 2012 |
24 |
10. |
15969 |
Ivica Štefe |
Biochemistry and molecular biology |
Technical associate |
2010 - 2013 |
36 |
11. |
07561 |
PhD Boris Turk |
Biochemistry and molecular biology |
Head |
2010 - 2013 |
1,037 |
12. |
01085 |
PhD Vito Turk |
Biochemistry and molecular biology |
Researcher |
2012 - 2013 |
1,490 |
13. |
33762 |
PhD Robert Vidmar |
Biochemistry and molecular biology |
Technical associate |
2012 - 2013 |
148 |
14. |
32171 |
PhD Matej Vizovišek |
Biochemistry and molecular biology |
Junior researcher |
2010 - 2013 |
142 |
Organisations (1)
no. |
Code |
Research organisation |
City |
Registration number |
No. of publicationsNo. of publications |
1. |
0106 |
Jožef Stefan Institute |
Ljubljana |
5051606000 |
90,682 |
Abstract
Many physiological processes, including tissue development and homeostasis, require a balance between cell death and cell proliferation, whereas even slight imbalance of the system may stimulate proliferation of the cell, facilitating its' oncogenic transformation. There is increasing evidence that lysosomes and/or lysosomal proteases are importantly players in both cell death and cell proliferation, in addition to their critical role in autophagy, which is considered a major survival mechanism of cancer cells. However, molecular mechanisms underlying lysosome and lysosomal protease involvement in these processes are still not well understood.
The main idea of this proposal is to identify the lysosomal protease signaling pathways in cell death and autophagy with a long-term goal to unravel the role of lysosomes and their components in hyperproliferative disorders such as cancer and their potential in anticancer treatment. This is based on a hypothesis that lysosomes and/or lysosomal proteases represent one of the major modulators of cellular signaling in these processes.
This project should thus provide a fundamental insight into how lysosomes and lysosomal proteases promote cellular signaling in cell death. The gained knowledge will significantly contribute to our understanding of the complex biological phenomena and will be instrumental for biomedical research to understand and develop novel strategies to combat cancer and other hyperproliferative diseases based on the modulation of the activities of lysosomal proteases.
Significance for science
This project was certainly of high biomedical relevance. Lysosomes and lysosomal proteases have already been validated as relevant targets for cancer treatment, whereas several compounds targeting lysosomes and/or lysosomal proteases are already in preclinical or clinical testing. This is true not only for LeuLeuOMe, which entered Phase I clinical trials, but also for TNF-related death receptor ligands and various antioxidants. We believe that we have opened new avenues in the areas where the exact roles of lysosomes and cathepsins and their signaling pathways were unknown, largely unclear or controversial such as in the death receptor pathway and caspase independent cell death. The gained knowledge will thus not only significantly contribute to our understanding of the complex biological phenomena, but will in long run also be instrumental in biomedical research to understand and develop novel strategies to combat cancer and other hyperproliferative diseases based on modulation of the activities of lysosomal proteases. In addition, the project strengthened the research at the Department of Biochemistry and Molecular Biology at Jožef Stefan Institute in the field of cell biology and molecular medicine.
Significance for the country
Cancer is one of the most debilitating diseases of the developed world. Therapeutic removal of cancer cells by stimulating apoptosis and blocking autophagy, together with the use of protease inhibitors, are currently among the most perspective areas in cancer treatment. Thus, the results obtained will be highly relevant in evaluation of lysosomes and cysteine cathepsins as possible therapeutic targets in cancer. Continuation of the research in representative animal cancer models is therefore of high value for the evaluation of compounds at the preclinical level, which should be interesting for the pharmaceutical companies in Slovenia and abroad. Therefore we can say that although the research performed was largely basic research, it also has its applied component and can be classified as strategic basic research. This also helped us to establish contacts with our SME Acies d.o.o, which was also one of the longterm goals of the project. Similar connections have already been established in past, as seen from the numerous contracts. Moreover, the work also offered great opportunity for students to be trained in the most advanced methods and areas, such as proteomics (at IJS in our Depatment we have the only protoemics lab in Slovenia), and chemogenomics together with European and other international partners. Both fields have namely high international priority as they are of extreme importance in target identification and validation during drug development. In addition, members of the project have received widespread international recognition, which is very important for the worldwide promotion of Slovenia and as such also for preservation of national identity of Slovenia.
Most important scientific results
Annual report
2010,
2011,
2012,
final report,
complete report on dLib.si
Most important socioeconomically and culturally relevant results
Annual report
2010,
2011,
2012,
final report,
complete report on dLib.si